Presentations

15:30

Outcomes of Kidney Transplantation From Organ Donation After Medical Assistance in Dying (MAiD): The University Health Network Experience

Angel Ngo (CA)

Bio Abstract

15:40

One-year survival and function of allogeneic beta-cells with no immunosuppression

Xiaomeng Hu (US)

Bio Abstract

15:50

Donor outcomes in living donor liver transplantation for acute liver failure – a prospective cohort study from the International LDLT Registry

Marina Berenguer (ES)

Bio Abstract

15:57

Multimodal Baseline Renal Function Assessment Improves Prediction of One-Year eGFR After Living Kidney Donation

Rehan Ansari (US)

Bio Abstract

16:04

First In human Successful CRISPR/Cas9 Gene Therapy (Exagamglogene Autotemcel) in a Heart Transplant Recipient with Beta-Thalassemia Major

Rabi Hanna (US)

Bio Abstract

16:09

Understanding the Relationship Between Pre-Implantation Kidney Allograft Biopsies and Early Transplant Outcomes: Insights from a Canadian Transplant Centre

Sang Joseph Kim (CA)

Bio Abstract

16:14

Allogeneic transplantation of human induced pluripotent stem cell-derived islet cells in a patient with type 1 diabetes

Kei Yamane (JP)

Bio Abstract

16:19

Non-invasive assessment of steatosis in living liver donors: Correlation of shear wave elastography and blood cholesterol with histology

Erdenebileg Bavuujav (MN)

Bio Abstract